New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2013
10:03 EDTDELL, LULU, FISV, UAL, AMTD, AXP, BHP, SYA, VRTX, WSO, SSRI, PFG, LOGI, AFL, RKT, PDCO, DY, ARMH, SIRO, REGN, PAAS, BIIBOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ARM Holdings (ARMH) downgraded to Equal Weight from Overweight at Morgan Stanley... Aflac (AFL) downgraded to Neutral from Buy at Sterne Agee... Biogen (BIIB) downgraded to Neutral from Buy at BofA/Merrill... Dycom (DY) downgraded to Outperform from Strong Buy at Raymond James... Logitech (LOGI) downgraded to Underperform from Neutral at Credit Suisse... Pan American Silver (PAAS) downgraded to Hold from Buy at Deutsche Bank... Patterson Companies (PDCO) downgraded to Sell from Neutral at Goldman... Principal Financial (PFG) downgraded to Neutral from Buy at Sterne Agee... Regeneron (REGN) downgraded to Hold from Buy at Jefferies... Rock-Tenn (RKT) downgraded to Buy from Conviction Buy at Goldman... Silver Standard (SSRI) downgraded to Sell from Hold at Deutsche Bank... Sirona Dental (SIRO) downgraded to Neutral from Buy at Goldman... Symetra Financial (SYA) downgraded to Underperform from Neutral at Sterne Agee... TD Ameritrade (AMTD) downgraded to Neutral from Buy at Sterne Agee... Watsco (WSO) downgraded to Neutral from Outperform at RW Baird... BHP Billiton (BHP) downgraded to Hold from Buy at Dahlman Rose... United Continental (UAL) downgraded to Neutral from Overweight at JPMorgan... Vertex (VRTX) downgraded to Neutral from Buy at Lazard Capital... American Express (AXP) downgraded to Underweight from Neutral at JPMorgan... Fiserv (FISV) downgraded to Equal Weight from Overweight at First Analysis... lululemon (LULU) downgraded to Underperform from Neutral at Buckingham... Dell (DELL)downgraded to Neutral from Buy at Monness Crespi.
News For ARMH;AFL;BIIB;DY;LOGI;PAAS;PDCO;PFG;REGN;RKT;SSRI;SIRO;SYA;AMTD;WSO;BHP;UAL;VRTX;AXP;FISV;LULU;DELL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 >>
August 18, 2015
10:00 EDTLULUOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abercrombie & Fitch (ANF) initiated with an Underperform at Wolfe Research... Abiomed (ABMD) initiated with a Buy at CRT Capital... Aeropostale (ARO) initiated with a Peer Perform at Wolfe Research... American Eagle (AEO) initiated with an Outperform, Top Pick at Wolfe Research... American Electric (AEP) initiated with a Buy at Mizuho... Benefitfocus (BNFT) initiated with an Overweight at First Analysis... Blue Buffalo Pet Products (BUFF) initiated with an Equal Weight at Morgan Stanley... Capitala Finance (CPTA) initiated with an Equal Weight at Stephens... Chico's (CHS) initiated with a Peer Perform at Wolfe Research... Children's Place (PLCE) initiated with an Outperform at Wolfe Research... Chimerix (CMRX) initiated with an Outperform at FBR Capital... Ciena (CIEN) initiated with a Market Perform at Northland... Crane (CR) initiated with an Outperform at William Blair... Entergy (ETR) initiated with a Neutral at Mizuho... Express (EXPR) initiated with an Outperform, Top Pick at Wolfe Research... Finisar (FNSR) initiated with a Market Perform at Northland... Francesca's (FRAN) initiated with a Peer Perform at Wolfe Research... Gap (GPS) initiated with an Underperform at Wolfe Research... Infinera (INFN) initiated with an Outperform at Northland... International Game (IGT) initiated with a Buy at Union Gaming... Juno Therapeutics (JUNO) initiated with an Outperform at FBR Capital... L Brands (LB) initiated with a Peer Perform at Wolfe Research... Luca Technologies (LUCA) initiated with an Outperform at Northland... Lumentum (LITE) initiated with an Outperform at Northland... M/A-COM (MTSI) reinstated with a Buy at Jefferies... MRV Communications (MRVC) initiated with an Outperform at Northland... Michael Kors (KORS) initiated with a Peer Perform at Wolfe Research... NN, Inc. (NNBR) initiated with a Buy at Stifel... NeoPhotonics (NPTN) initiated with an Outperform at Northland... Oclaro (OCLR) initiated with an Outperform at Northland... Scientific Games (SGMS) initiated with a Buy at Sterne Agee CRT... SolarCity (SCTY) initiated with a Neutral at UBS... Summit Materials (SUM) initiated with a Neutral at Citi... Tech Data (TECD) initiated with an Underperform at BofA/Merrill... Urban Outfitters (URBN) initiated with a Peer Perform at Wolfe Research... Zumiez (ZUMZ) initiated with an Underperform at Wolfe Research... lululemon (LULU) initiated with a Peer Perform at Wolfe Research.
10:00 EDTPFGOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:34 EDTPDCOPatterson Companies may be considering going private, says Northcoast
Subscribe for More Information
08:21 EDTBIIBBiogen long-term outlook still positive, says RBC Capital
Subscribe for More Information
07:05 EDTBIIBBiogen, ALS Association, Columbia collaborate to drive understanding of ALS
Biogen, the ALS Association and Columbia University Medical Center announced a new collaboration to better understand the differences and commonalities in the ALS disease process and how genes influence the clinical features of the disease. The project, "Genomic Translation for ALS Clinical care", will involve a combination of next generation genetic sequencing and detailed clinical phenotyping in 1500 people with ALS. The goal of the project is to provide a basis for the development of precision medicine, or more individually tailored therapies for ALS. "We want to bring genomics right to the point of care in ALS where instead of focusing on retrospective DNA samples with limited clinical information, we focus on patients who are under active clinical management," said ALS Association Chief Scientist Lucie Bruijn, Ph.D., M.B.A. "By focusing on patients seen by participating ALS clinics, this project will allow investigators to ask how different genetic causes of ALS translate into different clinical consequences."
05:37 EDTPFGPrincipal Financial downgraded to Market Perform from Outperform at Keefe Bruyette
Subscribe for More Information
August 17, 2015
16:57 EDTLULUlululemon initiated with a Peer Perform at Wolfe Research
Target $65.
16:48 EDTAXPValueAct discloses 11.1M share stake in American Express in 13F filing
Subscribe for More Information
12:02 EDTAXPAmerican Express reports July net write-off rate 1.3% vs. 1.3% last month
Subscribe for More Information
07:39 EDTDELLTMC to hold a conference
Subscribe for More Information
07:03 EDTBIIBBiogen: Clinical data supports long-term safety, efficacy of Alprolix
New clinical data support the long-term safety and efficacy of ALPROLIX in people with severe hemophilia B treated for up to two years, Biogen announced. Participants in the Phase 3, open-label extension study, B-YOND, maintained low bleeding rates with one to two week prophylaxis regimens, according to data from an interim analysis. Investigators presented these interim results for the first time at the 67th Annual Meeting for the National Hemophilia Foundation in Dallas. B-YOND is a multi-year study for people with severe hemophilia B who completed the Phase 3 pivotal B-LONG or Kids B-LONG studies. In this interim analysis, the median time on ALPROLIX during B-YOND was 27.6 months for adults and adolescents, and 47.7 weeks for children under age 12. The study's primary endpoint is inhibitor development, and no inhibitors have been reported to-date. There were three prophylactic dosing options for adult, adolescent, and pediatric participants in the B-YOND trial - weekly, individualized, and modified prophylaxis. An episodic treatment arm was also available for adult and adolescent patients.
06:22 EDTVRTX, REGNPiper's Tenthoff sees select biotech names outperforming in second half
Piper Jaffray analyst Edward Tenthoff expects drug launches, clinical data read-outs and potential partnerships to drive outperformance for select biotech names in the second half of 2015. Despite some recent profit-taking, 2015 has been another strong year for biotech stocks, Tenthoff tells investors in a research note. Names with important second half of the year catalysts include Vertex (VRTX), Regeneron (REGN), Seattle Genetics (SGEN), Exelixis (EXEL), Sarepta (SRPT), Novavax (NVAX), Arrowhead (ARWR), Array BioPharma (ARRY), Alnylam (ALNY), Genocea (GNCA), CymaBay (CBAY), Idera Pharmaceuticals (IDRA), Vitae Pharmaceuticals (VTAE).
August 16, 2015
18:20 EDTUALFAA working with airlines to restore operations after August 15 cancellations
Subscribe for More Information
August 14, 2015
16:37 EDTUALAppaloosa gives quarterly update on stakes, takes stake in Apple
Subscribe for More Information
10:33 EDTLULUOptions with increasing implied volatility
Subscribe for More Information
10:02 EDTSYAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:00 EDTBIIBStocks with implied volatility below IV index mean; BIIB GOOG
Subscribe for More Information
05:58 EDTSYASymetra Financial downgraded to Hold from Buy at Jefferies
Subscribe for More Information
05:16 EDTPAASPan American Silver backs FY15 production view of 25.5M-26.5M silver oz.
Subscribe for More Information
05:14 EDTPAASPan American Silver reports Q2 adjusted EPS (7c), consensus (9c)
Subscribe for More Information
1 | 2 | 3 | 4 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use